Vivos Achieves Landmark FDA Clearance for Sleep Apnea Solution
Dentistry Today
DECEMBER 1, 2023
(NASDAQ: VVOS), a prominent medical device and technology company specializing in developing and commercializing highly effective proprietary treatments for sleep-related breathing disorders, announced today that it has received 510(k) clearance from the U.S. Average treatment time was just 9.7
Let's personalize your content